%Patient characteristics of the 272 patients entered into study
| Characteristic . | DFMO-PCV arm . | PCV arm . |
|---|---|---|
| Number | 134 | 138 |
| Female patients | 51 (38%) | 36 (26%) |
| Median age (range), yr | 52.7 (20–75) | 49.6 (18–75) |
| Karnofsky performance score | ||
| 100 | 16 (12%) | 28 (20%) |
| 90 | 73 (54%) | 68 (49%) |
| 80 | 38 (28%) | 29 (21%) |
| 70 | 7 (5%) | 13 (9%) |
| Median radiation dose (range), Gy | 60 (40.4–72) | 60 (50–70.4) |
| Diagnosis to registration (range), weeks | 12.9 (8.1–21.0) | 12.4 (7.0–18.0) |
| Registered and followed at MDACC | 50 (37%) | 38 (28%) |
| Extent of surgery | ||
| Biopsy | 20 (15%) | 23 (17%) |
| Subtotal resection | 63 (47%) | 67 (49%) |
| Gross total resection | 51 (38%) | 48 (35%) |
| Characteristic . | DFMO-PCV arm . | PCV arm . |
|---|---|---|
| Number | 134 | 138 |
| Female patients | 51 (38%) | 36 (26%) |
| Median age (range), yr | 52.7 (20–75) | 49.6 (18–75) |
| Karnofsky performance score | ||
| 100 | 16 (12%) | 28 (20%) |
| 90 | 73 (54%) | 68 (49%) |
| 80 | 38 (28%) | 29 (21%) |
| 70 | 7 (5%) | 13 (9%) |
| Median radiation dose (range), Gy | 60 (40.4–72) | 60 (50–70.4) |
| Diagnosis to registration (range), weeks | 12.9 (8.1–21.0) | 12.4 (7.0–18.0) |
| Registered and followed at MDACC | 50 (37%) | 38 (28%) |
| Extent of surgery | ||
| Biopsy | 20 (15%) | 23 (17%) |
| Subtotal resection | 63 (47%) | 67 (49%) |
| Gross total resection | 51 (38%) | 48 (35%) |